On this page you will find links to key resources and tools designed to aid COVID-19 diagnosis, as well as the latest information regarding the ongoing developement of diagnostic tools and procedures
Are you considering conducting a diagnostic study? If so, then please let us know what you have planned and if you need any support. Are you looking for groups to collaborate with? Do you want to let others know that you would like to collaborate with another group?
We want to support any team wanting to undertake a high-quality COVID-19 study in different settings, and especially in LMICs. We can help coordinate discussions and support your plans. We can also set up a forum for developing ideas and asking questions. Please get in touch and get involved!
USE THE LINKS BELOW TO NAVIGATE DIAGNOSTICS:
What Support is Available?
Coronavirus disease (COVID-19) outbreak – Emergency Use Listing Procedure (EUL) announcement
The Emergency Use Listing Procedure (EUL) is developed to expedite the availability of in vitro diagnostics (IVDs) needed in public health emergency situations. The WHO Prequalification Team has announced that the EUL will now be open to candidate IVDs to detect SARS-CoV-2. An invitation to manufacturers of IVDs to detect SARS-CoV-2 to submit an Expression of Interest (EOI) for assessment of candidate IVDs under the EUL procedure was issued on 28 February 2020. Manufacturers who are interested in an EUL submission for assays to detect SARS-CoV-2 are invited to contact firstname.lastname@example.org to arrange a pre-submission meeting/call. Further information can be found here.
European Virus Archive – Global
The European Virus Archive - Global (EVAg) has simplified its procedure for the supply of molecular diagnostics control and viral strains to the scientific community worldwide. COVID-19 diagnostic controls and viral strains can now be receieved free of charge. Enquiries will be forwarded to a Selection Panel that will evaluate the demand based on criteria defined in the European Commission specific provisions for transnational access activities guidelines.
In response to the emergence of COVID-19, the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) has developed a portfolio of resources to accelerate outbreak research and response.
Fundação Oswaldo Cruz (Fiocruz) has created a resource area highlighting important sources of information about the pandemic, to facilitate the circulation of knowledge and help the entire scientific community to keep abreast of the latest news about the disease.